MABVAX THERAPEUTICS HOLDINGS, INC. Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MABVAX THERAPEUTICS HOLDINGS, INC. for April 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 07 2015 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | Director | Grant | A | 0.00 | 20,000 | 0 | 33,551 | 13.6 K to 33.6 K (+147.59 %) |
Apr 07 2015 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Director | Grant | A | 0.00 | 131,500 | 0 | 131,500 | 0 to 131.5 K |
Apr 07 2015 | MBVX | MABVAX THERAPEUTIC ... | Livingston Philip O. | Chief Science Offic ... | Grant | A | 0.00 | 1,000,000 | 0 | 1,307,396 | 307.4 K to 1.3 M (+325.31 %) |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Scholz Wolfgang W. | VP of Antibody Disc ... | Option Exercise | A | 0.00 | 304,750 | 0 | 304,750 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Scholz Wolfgang W. | VP of Antibody Disc ... | Option Exercise | A | 2.30 | 304,750 | 700,925 | 304,750 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | Vice President | Option Exercise | A | 0.00 | 334,000 | 0 | 334,000 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAFFUID PAUL W | Vice President | Option Exercise | A | 2.30 | 334,000 | 768,200 | 334,000 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Ravetch Jeffrey V. | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | MAIER PAUL V | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HOFFMAN ROBERT | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | Chief Financial Off ... | Option Exercise | A | 0.00 | 467,600 | 0 | 467,600 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSON GREGORY P | Chief Financial Off ... | Option Exercise | A | 2.30 | 467,600 | 1,075,480 | 467,600 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | President and CEO | Option Exercise | A | 0.00 | 903,250 | 0 | 903,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | HANSEN JOHN DAVID | President and CEO | Option Exercise | A | 2.30 | 903,250 | 2,077,475 | 903,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Director | Option Exercise | A | 0.00 | 34,250 | 0 | 34,250 | |
Apr 03 2015 | MBVX | MABVAX THERAPEUTIC ... | Cohen Kenneth M | Director | Option Exercise | A | 2.30 | 34,250 | 78,775 | 34,250 |